“Increasing Adoption of Sodium Lactate in Intravenous and Injectable Formulations”
- A key trend in the sodium lactate market for pharmaceutical industries is the growing use of sodium lactate in IV and injectable solutions for fluid resuscitation, pH buffering, and electrolyte balance, driven by clinical demand and hospital use
- The rise in surgeries, emergency care admissions, and the need for lactated Ringer’s solutions is contributing to the higher adoption of sodium lactate in parenteral preparations
- For instance, in January 2024, B. Braun launched a new range of lactated Ringer’s injectable solutions with sodium lactate as a key buffering agent across major Asian and European hospitals
- Pharmaceutical manufacturers are expanding their sterile production capabilities to meet regulatory-grade demand for injectable excipients such as sodium lactate
- With growing global health concerns, especially related to dehydration, sepsis, and acidosis management, sodium lactate is gaining traction in therapeutic application
- This trend is reshaping manufacturing investments and product portfolios in the pharma sector, with sodium lactate playing a central role in emergency and critical care drug formulations
